M&G Investments contributed £35m to the £195m private transaction alongside Temasek, Wellington Management, and Nikon.
"The technology developed by Oxford Nanopore is being used in a broad range of scientific research applications, including to further biomedical science, to characterise pathogens in microbiology and public health. This is an example of how institutional investors can play an important role in accelerating growth in companies that provide a wider benefit to society."
The financing brings total Series A funds to $33m to advance the company cell reprogramming pipeline.
"We are delighted to see the continued support of our existing investors, as well as welcome new investors Astellas Venture Management and Dr Jonathan Milner, in support of the progression of our initial programs through to IND-enabling studies."
The round was backed by FSE Group, Armajaro Holdings, Smith & Williamson, and Carlisle Commerce Group LLC.
"As a group we realised the benefits of developing our digital marketing strategy. We realised there was an opportunity to grow our database and promotional presence in the online market across our venues by developing our ticket selling platform. We looked at various systems on the market and felt that FIXR was the best fit for our business. The platform offers some key operational functions that benefitted both the consumer and venue management allowing a quick and easy customer journey when purchasing alongside a platform that allows the manager to be in complete control of their online offering 24/7."
Suss Ventures has sourced a six-figure sum to support the robotics start-up ahead of its commercial launch.
"The support from Suss ventures was key to put us in front of an early-stage fund that could act as lead investor. Their team has been extremely professional all the way through the process, looking for ways to improve our communication with prospective investors and creating a network of start-ups in similar stages. They have been and continue to be a very valuable asset for us in our current funding round and hopefully for the next ones to come."